| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
Moiz Rehmanjee
DFI | Director of Finance/CFO | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 30/09/2016 | |
| Chairman | - | 26/10/2017 | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -.--% | -.--% | - | - | 24.88M | ||
| +0.28% | +3.46% | +41.89% | +93.71% | 1,054B | ||
| +0.88% | +4.27% | +38.28% | +68.70% | 636B | ||
| +1.68% | +5.78% | +21.96% | +89.56% | 497B | ||
| -0.10% | +4.24% | +69.15% | +40.41% | 359B | ||
| +1.56% | +4.60% | +26.13% | +43.46% | 345B | ||
| +1.22% | +3.79% | +16.38% | +38.96% | 273B | ||
| +1.73% | +2.48% | -3.69% | +11.66% | 246B | ||
| +0.65% | +3.62% | +43.93% | +46.50% | 226B | ||
| -0.49% | +4.01% | +28.38% | +95.97% | 187B | ||
| Average | +0.60% | +3.14% | +31.38% | +58.77% | 424.69B | |
| Weighted average by Cap. | +0.50% | +3.19% | +34.53% | +67.59% |
Employees
-
Sector
Pharmaceuticals
















